Evidence map›Paper›PMID 33513808›Full record

ArticleInternational journal of molecular sciences2021

Andressa Vilas Boas Nogueira, Marjan Nokhbehsaim, Anna Damanaki, Sigrun Eick, Christian Kirschneck, Agnes Schröder, Jonathan Jantsch, James Deschner

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Prevalence ofPathogens (Basel, Switzerland) · 2026
    Observational
  3. Frontiers in cellular and infection microbiology · 2026
    Article
  4. Article
  5. Article
  6. Apelin Counteracts the Effects ofInternational journal of molecular sciences · 2024
    Article
  7. The impact ofFrontiers in dental medicine · 2024
    Review
  8. Article
  9. Article
  10. Review
  11. Apelin Enhances the Effects ofInternational journal of molecular sciences · 2023
    Article
  12. Article
  13. Proteomic Characterization of the Oral PathogenPathogens (Basel, Switzerland) · 2022
    Article
  14. Review
  15. Adipokines as Immune Cell Modulators in Multiple Sclerosis.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Andressa Vilas Boas NogueiraDepartment of Periodontology and Operative Dentistry, University Medical Center, University of Mainz, 55131 Mainz, Germany.ORCID 0000-0002-2756-5947
Marjan NokhbehsaimSection of Experimental Dento-Maxillo-Facial Medicine, Center of Dento-Maxillo-Facial Medicine, University of Bonn, 53111 Bonn, Germany.
Anna DamanakiDepartment of Periodontology and Operative Dentistry, University Medical Center, University of Mainz, 55131 Mainz, Germany.ORCID 0000-0002-2706-398X
Sigrun EickLaboratory of Oral Microbiology, Department of Periodontology, School of Dental Medicine, University of Bern, CH-3010 Bern, Switzerland.ORCID 0000-0002-4619-2461
Christian KirschneckDepartment of Orthodontics, University of Regensburg, 93053 Regensburg, Germany.ORCID 0000-0001-9473-8724
Agnes SchröderDepartment of Orthodontics, University of Regensburg, 93053 Regensburg, Germany.ORCID 0000-0001-6010-9831
Jonathan JantschInstitute of Clinical Microbiology and Hygiene, University Hospital Regensburg, 93053 Regensburg, Germany.
James DeschnerDepartment of Periodontology and Operative Dentistry, University Medical Center, University of Mainz, 55131 Mainz, Germany.
Johannes Gutenberg University Mainz · DEUniversity of Regensburg · DEUniversity Hospital Regensburg · DEUniversity of Bern · CHUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is little known about the effect of the periodontopathogen

Indexed as

Antigens, CDAntigens, Differentiation, MyelomonocyticB7-2 AntigenCD163 AntigenCD68 MoleculeCyclooxygenase 2EubacterialesGingivaHumansImmunohistochemistryLipopolysaccharide ReceptorsMacrophagesMAP Kinase Signaling SystemMatrix Metalloproteinase 1Nicotinamide PhosphoribosyltransferasePeriodontitisAntigens, CDAntigens, Differentiation, MyelomonocyticB7-2 AntigenCD163 AntigenCD68 antigen, humanCD68 MoleculeCyclooxygenase 2Lipopolysaccharide ReceptorsMatrix Metalloproteinase 1MMP1 protein, humanNicotinamide PhosphoribosyltransferaseReceptors, Cell SurfaceTLR2 protein, humanToll-Like Receptor 2Tumor Necrosis Factor-alphaCOX2Filifactor alocismacrophageMMP1periodontitistumor necrosis factorvisfatin

Identifiers

PMID33513808
PMCPMC7865436
OpenAlexW3122468326

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.